Please assess the completion status of the following clinical trial:

Trial Title: Observation Versus Immediate Surgery of Low Risk Bladder Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* History of low grade, noninvasive urothelial carcinoma of the bladder with a new recurrence that meets the following criteria:~* total tumor burden ≤3cm in size (multiple lesions permitted)~* low grade appearance (grade 1 or grade 2)~* noninvasive appearance (Ta)~* no history of carcinoma in situ (CIS) or lesions concerning for CIS~* negative urine cytology (atypical or suspicious for low grade neoplasm are acceptable)~Exclusion Criteria:~* High grade and/or invasive and/or carcinoma in situ disease~* Concomitant upper tract urothelial carcinoma~* Any patient who is pregnant or who may have plans to become pregnant.~* Positive cytology

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation (Type: OTHER): Patients will not undergo immediate surgery. These patients will undergo surveillance cystoscopy and urinary cytology every 3 months for 12 months. Surgery will commence after 12 months of observation or sooner if cystoscopic evidence of disease progression or patient desire.
- Immediate Surgery (Type: OTHER): Patients will undergo immediate surgery. These patients will undergo surveillance cystoscopy and urinary cytology every 3 months for 12 months. Repeated surgery will be offered for additional recurrences.

Based on this trial design, predict the completion outcome and termination type (if applicable).